News
News
Local News
Crime & Public Safety
Your Tax Dollars At Work
Politics
Massachusetts
Nation
World
Business
Health
Weather
Columnists
Traffic
Sports
Sports
Red Sox
Patriots
Celtics
Bruins
College
High School
More Sports
Scores & Stats
Entertainment
Entertainment
Celebrity News
Arts & Culture
Movies
Television
Music
Fun & Games
Horoscope
Lottery
Comics
Puzzles
Lifestyle
Lifestyle
Food & Beverage
Travel
Style & Fashion
Obituaries
Obituaries
Local Obituaries
Submit an Obituary
Opinion
Opinion
Editorials
Op-Ed
Letters
Submit a Letter
Radio
Weather
E-Edition
Subscribe
Sign Up For Newsletters
News
News
Local News
Crime & Public Safety
Your Tax Dollars At Work
Politics
Massachusetts
Nation
World
Business
Health
Weather
Columnists
Traffic
Sports
Sports
Red Sox
Patriots
Celtics
Bruins
College
High School
More Sports
Scores & Stats
Entertainment
Entertainment
Celebrity News
Arts & Culture
Movies
Television
Music
Fun & Games
Horoscope
Lottery
Comics
Puzzles
Lifestyle
Lifestyle
Food & Beverage
Travel
Style & Fashion
Obituaries
Obituaries
Local Obituaries
Submit an Obituary
Opinion
Opinion
Editorials
Op-Ed
Letters
Submit a Letter
Radio
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Articles published by Alector, Inc.
< Previous
1
2
Next >
Alector Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update
February 25, 2026
From
Alector, Inc.
Via
GlobeNewswire
Tickers
ALEC
Alector to Participate in the TD Cowen 46th Annual Health Care Conference
February 24, 2026
From
Alector, Inc.
Via
GlobeNewswire
Tickers
ALEC
Alector Appoints Neil Berkley as Chief Financial Officer and Chief Business Officer
December 12, 2025
From
Alector, Inc.
Via
GlobeNewswire
Tickers
ALEC
Alector to Participate in the Bank of America CNS Therapeutics Conference
December 01, 2025
From
Alector, Inc.
Via
GlobeNewswire
Tickers
ALEC
Alector Reports Third Quarter 2025 Financial Results and Provides Business Update
November 06, 2025
From
Alector, Inc.
Via
GlobeNewswire
Tickers
ALEC
Alector Announces Topline Results from Latozinemab Phase 3 Trial in Individuals with Frontotemporal Dementia Due to a GRN Mutation and Provides Business Update
October 21, 2025
From
Alector, Inc.
Via
GlobeNewswire
Tickers
ALEC
Alector to Host Virtual Research and Development Event Highlighting PGRN Franchise and Brain Carrier Programs
September 16, 2025
From
Alector, Inc.
Via
GlobeNewswire
Tickers
ALEC
Alector to Participate in Upcoming Healthcare Conferences
August 28, 2025
From
Alector, Inc.
Via
GlobeNewswire
Tickers
ALEC
Alector Reports Second Quarter 2025 Financial Results and Provides Business Update
August 07, 2025
From
Alector, Inc.
Via
GlobeNewswire
Tickers
ALEC
Alector to Host Second Quarter and Mid-Year 2025 Earnings Conference Call
July 31, 2025
From
Alector, Inc.
Via
GlobeNewswire
Tickers
ALEC
Alector Provides Executive Leadership Update
June 13, 2025
From
Alector, Inc.
Via
GlobeNewswire
Tickers
ALEC
Alector to Participate in the Goldman Sachs 46th Annual Global Healthcare Conference
June 03, 2025
From
Alector, Inc.
Via
GlobeNewswire
Tickers
ALEC
Alector Reports First Quarter 2025 Financial Results and Provides Business Update
May 08, 2025
From
Alector, Inc.
Via
GlobeNewswire
Tickers
ALEC
Alector to Participate in Upcoming Healthcare Conferences
May 06, 2025
From
Alector, Inc.
Via
GlobeNewswire
Tickers
ALEC
Alector Announces Completion of Enrollment in the PROGRESS-AD Phase 2 Clinical Trial of AL101/GSK4527226 in Individuals with Early Alzheimer’s Disease
April 17, 2025
From
Alector, Inc.
Via
GlobeNewswire
Tickers
ALEC
GSK
Alector Provides Executive Leadership Update
March 28, 2025
From
Alector, Inc.
Via
GlobeNewswire
Tickers
ALEC
Alector Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business Update
February 26, 2025
From
Alector, Inc.
Via
GlobeNewswire
Tickers
ALEC
Alector to Participate in Upcoming Healthcare Conferences
February 25, 2025
From
Alector, Inc.
Via
GlobeNewswire
Tickers
ALEC
Alector to Host Fourth Quarter and Full-Year 2024 Earnings Conference Call
February 19, 2025
From
Alector, Inc.
Via
GlobeNewswire
Tickers
ALEC
Alector Reports on Recent Progress and Outlines Strategic Priorities for 2025
January 13, 2025
From
Alector, Inc.
Via
GlobeNewswire
Tickers
ALEC
Alector Announces Results from AL002 INVOKE-2 Phase 2 Trial in Individuals with Early Alzheimer’s Disease and Provides Business Update
November 25, 2024
From
Alector, Inc.
Via
GlobeNewswire
Tickers
ALEC
Alector Secures Flexible Credit Facility for Up to $50 Million From Hercules Capital
November 14, 2024
From
Alector, Inc.
Via
GlobeNewswire
Tickers
ALEC
Alector Reports Third Quarter 2024 Financial Results and Provides Business Update
November 06, 2024
From
Alector, Inc.
Via
GlobeNewswire
Tickers
ALEC
Alector Presents Baseline Characteristics for Pivotal INFRONT-3 Phase 3 Clinical Trial at the 14th International Conference on Frontotemporal Dementias (ISFTD 2024)
September 19, 2024
From
Alector, Inc.
Via
GlobeNewswire
Tickers
ALEC
GSK
Alector to Participate in Upcoming Healthcare Conferences
August 29, 2024
From
Alector, Inc.
Via
GlobeNewswire
Tickers
ALEC
Alector Reports Second Quarter 2024 Financial Results and Provides Business Update
August 07, 2024
From
Alector, Inc.
Via
GlobeNewswire
Tickers
ALEC
Alector to Host Mid-Year Earnings Conference Call
July 31, 2024
From
Alector, Inc.
Via
GlobeNewswire
Tickers
ALEC
Alector Presents Baseline Characteristics for INVOKE-2 Phase 2 Clinical Trial of AL002 at the Alzheimer's Association International Conference® 2024 (AAIC®)
July 28, 2024
From
Alector, Inc.
Via
GlobeNewswire
Tickers
ABBV
ALEC
Alector to Present Data on Pipeline Focus Areas at the Alzheimer's Association International Conference® (AAIC®) 2024
July 23, 2024
From
Alector, Inc.
Via
GlobeNewswire
Tickers
ALEC
Alector to Participate in the H.C. Wainwright 5th Annual Neuro Perspectives Virtual Conference
June 20, 2024
From
Alector, Inc.
Via
GlobeNewswire
Tickers
ALEC
< Previous
1
2
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
Close